References
- O'Brien CP. Benzodiazepine use, abuse, and dependence. J Clin Psychiatry. 2005;66:28–33.
- Moosmann B, Huppertz LM, Hutter M, et al. Detection and identification of the designer benzodiazepine flubromazepam and preliminary data on its metabolism and pharmacokinetics. J Mass Spectrom. 2013;48:1150–1159.
- Moodmann B, King AL, Auwärter V. Designer benzodiazepines: a new challenge. World Psychiatry. 2015;14:2.
- Moosmann B, Bisel P, Auwärter V. Characterization of the designer benzodiazepine diclazepam and preliminary data on its metabolism and pharmacokinetics. Drug Test Anal. 2014;6:757–763.
- Schifano F, Orsolini L, Papanti GD, et al. Novel psychoactive substances of interest for psychiatry. World Psychiatry. 2015;14:15–26.
- Nakamae T, Shinozuka T, Sasaki C, et al. Case report: etizolam and its major metabolites in two unnatural death cases. Forensic Sci Int. 2008;20:182.
- Laloup M, Ramirez Fernandez Mdel M, De Boeck G, et al. Validation of a liquid chromatography-tandem mass spectrometry method for the simultaneous determination of 26 benzodiazepines and metabolites, zolpidem and zopiclone in blood, urine, and hair. J Anal Toxicol. 2005;29:616–626.
- Aljarallah S, Al-Hussain F. Acute fatal posthypoxic leukoencephalopathy following benzodiazepine overdose: a case report and review of the literature. BMC Neurol. 2015;15:69.
- [cited 2015 Sep 15]. Available from: http://tripbot.tripsit.me/factsheet/Flubromazolam.
- Huppertz LM, Bisel P, Westphal F, et al. Characterization of the four designer benzodiazepines clonazolam, deschloroetizolam, flubromazolam and meclonazepam and identification of their in vitro metabolites. Forensic Toxicol. 2015;33:388–395.